Carterra 23/09/25
LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

DDL 2025
SAE Media – pre-filled syringes EU 19/11/25
SAE Media – pre-filled syringes – East Coast 19/11/25
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

PCI Pharma Services

PCI Pharma Services provides world-class solutions through intelligence, ingenuity and innovation, together, delivering life-changing therapies. With integration from inception and quality at our core, PCI’s development, manufacturing, clinical trial services, advanced drug delivery and packaging capabilities combine to minimize time-to-market and maximize opportunities for commercial success. PCI serves as an extension of its customers’ value chains, toward the shared goal of improving patients’ lives.  

PCI Facts & Figures

  • 50+ years of healthcare sector service
  • 90+ successful product launches per year
  • 38 facilities across North America, Canada, UK, Ireland, Germany, Spain & Australia
  • 8,500+ highly skilled personnel
  • Emissions reduction goals validated by Science Based Targets initiative

Leveraging state-of-the-art technology and ongoing investment, PCI steers pharma products through their entire lifecycle via four key business segments:

Development & Manufacturing

From early clinical batches to worldwide commercial supply, PCI’s aseptic manufacturing, lyophilization and high potent oral dose manufacturing capabilities are trusted across formats and dosage forms. Through fully integrated formulation, analytical development and scalable manufacturing, PCI’s expertise in the science delivers the reproducibility required to take products from the earliest stages of clinical development to commercial launch. Excelling in complex modalities, PCI’s ever-evolving services meet emerging needs for cutting-edge sterile injectable filling and high-potency targeted therapies.

Advanced Drug Delivery & Drug-Device Combination Products

From prefilled syringes and needle safety devices to autoinjectors and pens, PCI provides unsurpassed capabilities in advanced drug delivery and drug-device combination products. Industry-unique clinical to commercial scale device assembly, testing and packaging are performed in unified, single-space environments, ensuring seamless continuity and expedited pathways. With the expertise to assemble devices from multiple micro-engineered components and global capacity for low-volume, high-mix and large-scale production, PCI pioneers solutions that set standards for dosing accuracy and patient-centricity. 

Clinical Trial Services

Transparent and collaborative from first dose to final phase, PCI’s clinical trial services ensure investigational drugs achieve accurate assessment and expedience through-phase advancement. Robust networks provide comprehensive oversight from specialized packaging to global logistics, with drug device integration, parallel work flows and built-in stability testing maintaining momentum toward approval. A dedicated Supply Management and Readiness Team (SMARTTM) reduces financial and resource risk, while pre-commercial consultancy and planning services serve as guideposts for client partners. Throughout, the award-winning pci | bridge™ platform provides our global client base with real-time data for faster, intelligent decision making.

Commercial Packaging Technology

Offering a deep bench of solutions for oral dosages, injectables and other dosage forms, PCI’s commercial packaging services prioritize quality, safety and precision. From proprietary systems and bespoke labeling modules to entirely new engineering approaches, PCI brings the extensive background and expansive footprint to meet countless end-of-line needs. Industry-leading and extensive labeling, printing, primary and secondary packaging capabilities developed over 5 decades combine with exacting visual inspection and traceability systems to protect products, supply chains and patients.

Contact Details

PCI Pharma Services HQ

3001 Red Lion Road
Philadelphia

PA 19114
USA
T: +1 215 613 3600

E: talkfuture@pciservices.com

W: www.pci.com

YPSOMED website ad
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
SAE Media – AI in DD
HCMed
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
Nipro – 09.06.2025
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025